Section 32.1-73.22 - [Effective 7/1/2024] Collection of sickle cell disease case information by the CommissionerA. Using such funds as may be appropriated therefor, the Commissioner or his designee may perform on-site data collection of the records of patients having sickle cell disease at those consenting hospitals, clinics, independent pathology laboratories, and physician offices required to report information on such patients pursuant to the reporting requirements of § 32.1-73.21 in order to ensure the completeness and accuracy of the statewide sickle cell disease registry.B. The selection criteria for determining which consenting hospitals, clinics, independent pathology laboratories, and physician offices may be subject to on-site data collection under the provisions of this section shall include (i) the expected annual number of sickle cell disease case reports from each such facility, (ii) the historical completeness and accuracy of reporting rates of each facility under consideration, and (iii) whether the facility maintains its own sickle cell disease registry.C. The Board shall promulgate regulations necessary to implement the provisions of this section.Added by Acts 2024 c. 437,§ 1, eff. 7/1/2024.